Victor Levin, M.D.
As a world renowned expert in brain tumor research and treatment, Dr. Levin is currently a practicing physician at the Kaiser Permanente Redwood City Hospital Department of Neurosurgery. He is a Professor Emeritus and former Chair of the Department of Neuro-Oncology for The University of Texas MD Anderson Cancer Center. Dr. Levin has previously held positions as Staff Associate in the Laboratory of Chemical Pharmacology of the U.S. National Cancer Institute ("NCI"), where he was involved in some of the original research related to VAL-083 and as a Professor in the Departments of Neurological Surgery, Neurology, Pharmaceutical Chemistry, and Pharmacology at the University of California San Francisco. He is also the founder and first president (1995-97) of Society for Neuro-Oncology. Dr. Levin holds B.S. and M.D. degrees from the University of Wisconsin and Neurology Residency at the Massachusetts General Hospital.
James Perry, M.D., FRCPC
Dr. Perry is the Chair of the Canadian Brain Tumour Consortium, a Canadian national not-for-profit investigator network where he currently leads or co-leads several international collaborative clinical trials. He is an Associate Scientist, Clinical Integrative Biology in the Odette Cancer Research Program at Sunnybrook Research Institute and an Associate Professor, Department of Medicine - Division of Neurology at the University of Toronto, where his research focuses on brain tumor treatment and patient care. Dr. Perry received his medical degree from the University of Toronto and is a Neurology Fellow of the Royal College of Physicians and Surgeons of Canada (FRCPC).
Dan Zhang, M.D., Ph.D., M.P.H.
Dr. Zhang is the Chairman Chief Executive Officer of Fountain Medical Development, and a member of the Chinese State Food and Drug Administration (SFDA) Oncology Advisory Board. Dr. Zhang was previously vice president at the Quintiles Transnational Corp., responsible for the planning and implementation of business development strategies in Greater China Area. Dr. Zhang received his M.D. from Peking Union Medical College. He continued his study at the Harvard School of Public Health and received an M.P.H. in health policy and management. Dr. Zhang continued his training at the Wharton Business School of the University of Pennsylvania, where he obtained his master's degree in healthcare management in 1998 and is working on his Ph.D. dissertation in the field of health economics and finance.